Effect of Utilizing Virtual Reality With Pulmonary Rehabilitation on Depression in COPD Patients
Effect of Utilzing Virtual Reality With Pulmonary Rehabilitation on Depression in COPD Patients: A Randomized Controlled Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
The goal of this study is to find the effect of utilizing virtual reality with pulmonary rehabilitation on depression in COPD patients. The main question it aims to answer is: Does utilizing virtual reality with pulmonary rehabilitation reduce depression in COPD patients?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 21, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 21, 2026
CompletedFirst Submitted
Initial submission to the registry
June 7, 2026
CompletedFirst Posted
Study publicly available on registry
August 27, 2026
CompletedAugust 27, 2026
August 1, 2026
4 months
June 7, 2026
August 25, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
depression
The primary outcome was the change in the depression score from baseline to post intervention. Depression was assessed prior to the first session of pulmonary rehabilitation program and reassessed after the completion of the twelfth session by Beck's Depression Inventory-II (BDI-II). BDI-II is a 21 item questionnaire which measures the severity of depression in adults and adolescents. It is structured on a 4 point rating scale for each question from 0 indicating no presence of any symptoms and 3 indicating that symptoms strongly present. Total scores from 0 to 13 indicate no or minimal depression, scores from 14 to 19 indicate mild depression, while scores from 20 to 28 indicate moderate depression, and scores from 29 to 63 indicate severe depression (Beck, A. T., 1996; NaviauxLab., 2020; Rahat et al., 2012). Patients with depressive symptoms score with a cut off of 14 as mild score indicating clinically significant were included in the study.
6 weeks
Secondary Outcomes (4)
anxiety
6 weeks
functional capacity
6 weeks
sequential attendance of pulmonary rehabilitation sessions
12 sessions
compliance with medication
12 sessions
Study Arms (2)
Experimental group
EXPERIMENTALcontrolled group
OTHERcontrolled group received pulmonary rehabilitation
Interventions
Virtual reality was utilized with pulmonary rehabilitation in COPD patients in the expiremental group
controlled group received pulmonary rehabilitation without utilizing virtual reality
Eligibility Criteria
You may qualify if:
- Patients with a confirmed diagnosis of COPD, aged between 45 and 85 years and presenting with depression according to the score of BDI-II with a cut off of 14 at the baseline assessment.
You may not qualify if:
- Absence of depression based on BDI-II score, presence of serious psychiatric disorders at the time of evaluation or documented in the medical records, initiation of psychiatric treatment during the study period, contraindications for virtual reality exposure such as (significant vision issues, significant hearing issues, severe motion sickness, seizure disorders) and the patient's refusal to participate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Qatif Central Hospital
Dammam, Eastern Province, Saudi Arabia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 7, 2026
First Posted
August 27, 2026
Study Start
February 2, 2026
Primary Completion
May 21, 2026
Study Completion
May 21, 2026
Last Updated
August 27, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share